Moreover, our data demonstrate that the autotaxin pathway, including autotaxin and the downstream mediator LPA1, is a promising therapeutic target to ameliorate the aggressive characteristics of mesotheliomas. The gene discussed is LPAR1; the disease is mesothelioma.